feed,title,long_url,short_url
Benzinga,"ChatGPT Parent OpenAI Aims At Budget-Friendly AI Innovations, Novo Nordisk's Popular Diabetes Drug Ozempic Faces Counterfeit Threat in Germany: Today's Top Stories",https://benzinga.com/news/23/10/35220687/chatgpt-parent-openai-aims-at-budget-friendly-ai-innovations-novo-nordisks-popular-diabetes-drug-oze,https://da.gd/KU2f1B
Benzinga,CO2 Capture: KBR Adds PureM Technology To Its Suite Of Sustainable Process Solutions,https://benzinga.com/markets/equities/23/10/35216649/co2-capture-kbr-adds-purem-technology-to-its-suite-of-sustainable-process-solutions,https://da.gd/2EhZZx
